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ABSTRACT 
 
 Prophylactic bilateral mastectomy (PBM) is the current recommended course of 
action for women with increased genetic risk for breast and ovarian cancer. Nevertheless, 
many receive negative feedback from family and friends surrounding the decision to 
undergo this surgery because they do not have cancer when the decision is made; this 
results in a limited support network for coping with their PBM. Low social support is 
associated with depression, negativity, and anxiety. Women who had a PBM, were 
currently undergoing or had completed reconstruction, and were in a committed romantic 
relationship at the time of the surgery were surveyed (N = 53). The hypotheses that 
women who received negative feedback about their decision to have a PBM would have 
poorer individual well-being, and that the use of a couples-based team approach would 
moderate these adverse effects were tested. Data analyses support the hypotheses that 
women in couples taking a team approach to PBM have better individual well-being. The 
effects of negative feedback from others about the decision to undergo a PBM on 
personal mental health were moderated by use of a couples-based team approach. 
Women who received negative feedback from multiple sources had better outcomes if 
they used a couples-based team approach. Many women have a preventative 
oophorectomy around the same time as their PBM. Menopause is associated with side 
effects such as increased vasomotor symptoms and decreased sexual functioning. The 
hypothesis that surgical menopause is related to declines in sexual satisfaction following 
PBM was also tested. Regression analysis revealed no relationship. This study indicates 
that women who experience social disapproval and lack collaborative support from their 
significant other may be at increased risk for poor individual well-being following PBM. 
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Introduction 
HBOC Genetic Mutations 
Hereditary breast and ovarian cancers (HBOC) are related to several genetic 
mutations that increase one’s risk of breast and ovarian cancer. BRCA 1 and BRCA 2 
mutation variants account for approximately 90% of HBOC genetic mutations (Ford et 
al., 1998), others include ATM, CHEK2, TP53, and BARD 1 (Caminsky, Mucaki, Perri, 
Lu, Knoll, & Rogan, 2016). These deleterious genetic mutations also increase the risk of 
cancer in other sites such as the stomach, skin, cervix, or prostate (Johannsson, Loman, 
Möller, Kristoffersson, Borg, & Olsson, 1999). Everyone has these genes, and numerous 
mutations or variants of each exist; however, not all are harmful, and some are even 
protective (Jabaley Leonarczyk & Mawn, 2015). Deleterious BRCA mutations confer up 
to 87% lifetime risk of developing breast cancer (Easton, Ford, & Bishop, 1995), and 28-
66% lifetime risk of developing ovarian cancer (Risch et al., 2001). These percentages 
vary by the specific mutation inherited. 
The general population has a breast cancer risk of approximately 12% 
(Howlander, 2017). With 1 in 8 women being diagnosed with breast cancer, it is likely 
that most people have a relative with breast cancer, or a family history of cancer. 
Although HBOC accounts for only about 5% to 10% of breast cancers and 25% of 
ovarian cancers (Caminsky et al., 2016), the high prevalence of non-hereditary cancer can 
cause a “family history” even without genetic mutation. Those with a strong family 
history of cancer, or who have an Ashkenazi Jewish ancestry coupled with ovarian cancer 
in the family, experience higher prevalence of HBOC mutations (Ford et al., 1998). 
Testing for genetic mutations can offer relief to recipients of negative results, while 
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positive tests can indicate courses of action for behavioral or medical interventions 
(Cameron, Sherman, Marteau, & Brown, 2009). Responses to unfavorable genetic test 
results include surveillance, chemoprevention, and surgery, as described below. 
Surveillance 
It is recommended that BRCA mutation carriers undergo surveillance, or cancer 
screening, every six months beginning at age 25 (Warner et al., 2004). For breast cancer 
screening, a regimen of self-exams, clinical exams, and imaging (MRI, ultrasound, 
mammogram) is used (Stan, Shuster, Wick, Swanson, Pruthi, & Bakkum-Gamez, 2013). 
For ovarian cancer screening, pelvic exams, pelvic ultrasound, and serum CA-125, a 
blood test which measures levels of cancer antigen 125 in the blood stream, may be used. 
The surveillance route is noninvasive, but suspicious or ambiguous findings can lead to 
additional testing and emotional distress (Stan et al., 2013). This may lead women to turn 
to surgery after experiencing fatigue from repeated emotionally exhausting and costly 
screening (Hoskins & Greene, 2012). 
Most women who choose surveillance are younger and without children. They 
often feel that they have time on their side and can select surgical options after reaching 
goals such as establishing their career or starting their family (Hesse-Beiber, 2014). 
Women may choose surveillance to delay surgery for goal planning (Hesse-Biber, 2014). 
These women may consider surgery not a matter of “if”, but rather “when”. This option 
may create the narrative of racing against time seen in several book and blog titles 
authored by mutation carriers (e.g., “Ticking Time-Bombs;” “Dangerous Boobies: 
Breaking up with My Time-Bomb Breasts”). There may also a sense of urgency to find a 
partner and have children prior to switching strategy to surgical options (Leonarczyk & 
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Mawn, 2015). Mastectomy removes the ability to breastfeed (Hoskins & Greene, 2012). 
For some women, breastfeeding is an important and emotional experience causing them 
to delay prophylactic bilateral mastectomy (PBM) until after weaning. Other women 
choose to have a PBM prior to pregnancy and forego breastfeeding. Most practitioners 
recommend removal of the ovaries and fallopian tubes, or prophylactic bilateral salpingo-
oophorectomy, after patients complete their families to further reduce their risk of cancer.  
Medicinal Interventions 
Chemoprevention therapy is another option for BRCA mutation carriers. 
Tamoxifen, an estrogen receptor modulator used to treat estrogen-dependent cancers, can 
also be used as a means for prevention (Bonanni & Lazzeroni, 2013). For mutation 
carriers, chemoprevention is used during remission from cancer to prevent contralateral 
recurrence; its effectiveness in this role led to trials of chemoprevention for mutation 
carriers prior any cancer occurrence.  One study found Tamoxifen reduced occurrence of 
invasive breast cancer by 49.5% (Fischer et al., 1998). Nevertheless, chemotherapy for 
prevention among mutation carriers is not commonly used and is quite controversial, with 
studies finding ratings of acceptability between 22.1% and 34% (Bonanni & Lazzeroni, 
2013). Associated adverse effects related to chemoprevention therapy include uterine 
cancer, stroke, cataracts, and thromboembolic events (Stan et al., 2013).  Therefore, 
tamoxifen is not recommended for those who have not had a hysterectomy or who have 
had previous deep vein thrombosis or pulmonary embolism (Kramer & Brown, 2004). 
Oral contraceptives (OC) may reduce risk for ovarian cancer by up to 50% (Iodice 
et al., 2010). There is some controversy with the use of OC as means for ovarian cancer 
prevention, however, because some findings suggest increased risk of breast cancer 
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(Gadducci, Biglia, Cosio, Sismondi, & Genazzani, 2010). One possible explanation for 
this is that OC formulations from prior to 1975 had higher doses of hormones. A meta-
analysis by Iodice and colleagues (2010) found that use of OC with the older formulation 
was related to increased risk, while use of the newer lower dose OCs is not.  
Surgery 
Prophylactic bilateral mastectomy. Women at increased risk for breast cancer 
may view PBM as an opportunity to gain control of their risk and avoid an “inevitable” 
cancer diagnosis (Hoskins & Greene, 2012). A PBM reduces the risk of getting breast 
cancer by 90% to 94% (Hartmann et al., 1999).  Following the PBM, an HBOC mutation 
carrier will have less risk for breast cancer than the average risk of the general 
population. 
There are several options with respect to breast reconstruction, with 
corresponding opportunities for complications to occur. Women may opt out of 
reconstruction altogether, choose a direct-to-implant procedure if they qualify, choose to 
reconstruct the breast by grafting tissue from another area, or choose to use expanders to 
create a space large enough to take an implant during a later surgery. During a skin-
sparing mastectomy, the subcutaneous breast tissue is removed, and the skin is retained 
allowing for reconstruction to begin (Singletary, 1996). The nipple-areolar complex is 
also breast tissue, so it is usually removed as well. Some women opt for a nipple-sparing 
mastectomy which preserves the nipple-areolar complex while removing the rest of the 
breast tissue. Recent studies have found comparable risk reduction outcomes for skin-
sparing and nipple-sparing mastectomy techniques (see Yao et al., 2015).   
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Quality of life after PBM.  A review of quality of life following PBM done by 
Razdan, Patel, Jewell & McCarthy (2016) found the majority of patients reported 
favorable results for PBM outcomes for psychosocial well-being and body image. Sexual 
well-being outcomes had mostly favorable, but mixed results. It is noted however, that 
many of the analyses in these studies were done with ad hoc instruments making it 
difficult to compare results. The most negative effect was on somatosensory function, 
such that women often experience loss of sensation or have continued pain and 
discomfort in the breast area.  
 In contrast, Lodder et al. (2002) reported less favorable results.  They investigated 
effects of genetic testing results by collecting data from a group of women at the time of 
receiving their results, and at 6 months and 12 months post-testing. Interestingly, they 
found that the group of women who had opted for mastectomy had lower body image and 
sexual relationship scores than both the group who tested negative and the group who 
tested positive but had opted for surveillance; scores were lower both at the time of 
receiving test results and after mastectomy. This finding of consistent lower body image 
scores beginning prior to PBM suggests that the surgery itself was not fully responsible 
for the low scores in this group. Women with positive test results may feel betrayed by 
their bodies resulting in poorer body image (BuzzFeed Video, 2017). Lodder noted that 
they did not use a validated scale to measure body image, so the extent of the problem 
may not be clear.   
Gopie and colleagues (2013) also found some negative impact from PBM on body 
image. Women with high preoperative cancer distress scores experienced decreased body 
image at 6 months following PBM and at the post-reconstruction follow-up, 21 months 
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after receiving test results on average. There were many women in this sample who had 
body image issues prior to their PBM that did not change following reconstruction. Gopie 
also used an ad hoc, study-specific body image scale in their analyses. Although overall 
partner relationship satisfaction did not change over time, there was a trend of decline for 
sexual relationship satisfaction. It is possible that this trend may be related to the co-
ocurrence of risk-reducing prophylactic bilateral salpingo-oophorectomy (PBSO; see 
below).  
 Several studies, even those in which a majority of participants with favorable 
outcomes, uncovered similar factors leading to dissatisfaction (Lodder et al., 2002; 
Bresser et al., 2006). Surgical complications, changed appearance affecting femininity, 
changes in sexual activity, and unnatural-looking or -feeling results were contributing 
factors. In addition, women whose physicians strongly recommended PBM were worse 
off than those who came to the decision on their own (Gopie et al., 2013; Razdan et al., 
2016). Other contributons to poorer adjustment were unmet expectations and lack of 
information (Bresser et al., 2006; Lodder et al., 2002). Overall, however, very few 
women across studies regretted their decision to have a PBM, and many studies reported 
no participant regret regarding their decision. The only participant with regret from 
Lodder’s study (2002) cited the lack of information regarding psychosocial consequences 
and effects on physical well-being as the cause of her regret. 
Prophylactic bilateral salpingo-oophorectomy.  PBSO reduces the risk of 
ovarian cancer 80%–85% and breast cancer 50%–72% risk in BRCA carriers (Matloff, 
Barnett, & Bober, 2009). Many BRCA related breast cancers are estrogen sensitive and 
therefore removal of the ovaries reduces the risk of breast cancer. Removal of the ovaries 
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results in immediate menopause which has been related to an increase in vasomotor 
symptoms and decrease in sexual functioning (Finch et al., 2011). Side effects can 
include vaginal dryness, decreased libido, and difficulty achieving orgasm (Matloff, 
Barnett, & Bober, 2009; Finch et al., 2011). Many women with HBOC mutations report 
not fully being informed of the impact this surgery may have. Similar to PBM, most 
women were satisfied with the decision to have their surgery regardless of any side 
effects (Finch et al., 2013). They felt that the risk reduction benefits out-weighed these 
other issues. No studies to our knowledge tested the potential influence of an 
accompanying risk-reducing PBSO on decline in sexual well-being or sexual relationship 
satisfaction associated with PBM. 
Recent research has indicated that hereditary ovarian cancer may originate in the 
fallopian tubes or other epithelial tissue and may therefore be secondary ovarian cancer 
rather than primary (Kwon et al., 2013). Women may opt to remove their fallopian tubes 
upon completion of child-bearing and delay removal of the ovaries until closer to the time 
of natural menopause. This option reduces their risk and is less costly in terms of 
potential effects on quality of life. 
A Different Kind of Decision-Making 
As noted above, those who receive positive test results for a deleterious HBOC 
mutation may utilize surveillance, medicinal interventions, or surgical procedures to 
manage their risk. The decision-making for this group differs from typical cancer-related 
decision-making. Survival is often at the forefront of decisions made to treat existing 
cancer and may outweigh any potentially negative psychosocial outcomes. Patients are 
presented with statistical information about potential treatment options and effects on 
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survival. In these situations, patients generally follow recommendations made by 
experienced healthcare professionals (Hesse-Biber, 2014).  
In contrast, women who have received positive genetic test results for an HBOC-
related mutation have not been diagnosed with cancer yet and have a more flexible 
decision-making timeline.  Decisions are driven not only by the statistical risk of 
developing cancer, but more prominently by a host of social factors, namely familial 
history, death of a close relative, and social or information support from a network of 
friends, family, and online groups (Hesse-Beiber, 2014). For example, death of a close 
relative as a result of cancer, especially a mother, predicts a woman’s selection of 
surgical options (Wenzel et al., 2012; Hesse-Beiber, 2014; Samama, Hasson-Ohayon, 
Perry, Morag, & Goldzweig, 2014). Women whose mothers battled cancer, but did not 
die, also preferred preventative surgery over a surveillance route (Hesse-Beiber, 2014). 
The question becomes, do you want to treat a disease you don’t have and might not even 
get? 
Social Disapproval of PBM 
There is controversy surrounding the decision to undergo PBM because women 
are not afflicted by cancer when the decision is made. Many women receive negative 
feedback from early confidants and ultimately decide not to inform or discuss with 
others, resulting in a limited support network (Lloyd et al., 2000). Friend or family 
disapproval of PBM discourages communication, which increases isolation. Family 
communication is important, as it has been linked to improved long-term adjustment and 
reduced breast cancer-specific and general distress (den Heijer et al., 2011; Lloyd et al., 
2000). A study by den Heijer and colleagues (2011) found that open family 
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communication about hereditary cancer risk was directly related to lower psychological 
distress and this effect was not mediated by social support. This demonstrates the 
importance of open communication within the family, which offers benefits regardless of 
other social support. Increasing family member understanding and willingness to discuss 
the implications of genetic risk and benefits of preventative options is a potential arena 
for future research or intervention.  
Impacts on Partners and Relationships 
There has not been much research on relationship adjustment for at-risk women 
undergoing PBM, although multiple studies suggest the effects of PBM on relationships 
should not be underestimated (Gopie et al., 2013). Any negative aspects felt at a personal 
level could affect the relationship as well. Depression, negativity, and anxiety that may be 
related to genetic test results and PBM are all widely known to be negatively correlated 
to marital functioning (Watts, Sherman, Mireskandari, Meiser, Taylor, & Tucker, 2011). 
Additionally, low self-esteem and body image combined with poor communication can 
have a profound negative impact on marriage (Rowland & Metcalfe, 2014). There is, 
however, more research on couples’ experiences with receiving genetic results indicating 
increased risk, and on couples’ or partner’s experience with mastectomy for existing 
cancer.  
PBM studies. A qualitative study by Lloyd et al. (2000) found that women’s 
greatest support came from their spouse. The spouse felt increased stress during the 
mastectomy and reconstruction in response to balancing work, taking care of the children, 
and supporting their wife. The initial surgery has about a 6-week recovery period, which 
not only imposes physical restrictions on the patient, but requires assistance from the 
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partner with self-care and housework, and likely requires a significant amount of time out 
of work leading to financial strain. The quality of the relationship prior to the PBM was 
related to the type of impact afterward. Couples with lower ratings of their relationship 
quality felt a negative impact, while those with higher ratings felt a positive impact. 
The study by Lodder et al. (2002) discussed previously also interviewed the partners 
of the women who had PBM. The decreases in intimacy seen were likely due to the 
women, rather than their partners, feeling inhibited. As with the Lloyd study, if there 
were pre-existing communications problems, they were compounded with the additional 
strain of the surgery and recovery.  
Genetic testing. A study looking at male partners of women who receive positive 
genetic testing results related to HBOC found they experience similar psychological 
concerns and distress as the women themselves (Mireskandari et al., 2006). Distress may 
be caused by suppressed communication, feeling the need to provide emotional support, 
and worries about future children inheriting the mutation (Metcalfe, Liede, Trinkaus, 
Hanna, & Narod, 2002). Another source of distress stems from the fear that their wife 
may develop or die of cancer; this can lead to changing future goals about careers or 
families in response to testing positive (Metcalfe et al., 2002). Challenges related to 
coping with increased risk of cancer may place strain on a couple’s relationship (Watts et 
al., 2011). Partners are often caught between providing support and managing their own 
distress (Sherman, Kasparian, & Miraskandari, 2009). Low levels of communication and 
partner support have been associated with higher distress at the time of genetic testing, 6 
months after, and up to 2 years after receiving positive genetic results. (Van Oostrom et 
al., 2007; Wylie, Smith, & Botkin, 2003). 
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 A 2016 qualitative study by Mauer, Spencer, Dungan, and Hurley that addressed 
changes within the relationship following genetic testing found that about 20% became 
less intimate, but 40% discussed the future more frequently. For those who had not yet 
had a PBM, there was high concern for their partner’s health or lifespan. There were also 
concerns about how having a PBM could affect their sexual relationship, and for the 
potential loss of breast sensation or attractiveness. 
Mastectomy for existing cancer. Many studies examining the effects of 
mastectomy on relationships or spouses have been done in the context of existing cancer. 
A review by Rowland and Metcalfe (2014) summarized the literature on male partners’ 
experiences of their wives’ breast cancer. Spouses were stressed by diagnoses, 
particularly anxious during decision making, felt death anxiety, and were bothered by 
partner’s distress or pain. A majority of men felt a negative impact on their sexual 
relationship, while others did not perceive this impact, were supportive, and encouraged 
positive body image in their partners. Some men were active in the decision-making 
process while others were removed, possibly as a defense mechanism, leading to closed 
communication. Some topics that were difficult to discuss include changes in intimacy 
and feelings about their wives’ altered body, because they felt this made them appear 
insensitive. 
 
Importance of Dyadic Communication 
Closed communication is associated with adverse outcomes for couples across 
studies exploring potential effects of mastectomy, genetic testing, and PBM. As 
mentioned previously, open communication is key to long-term individual adjustment. 
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Communication is also an essential facet of dyadic adjustment. Information from 
healthcare providers is usually directed at the patient, leaving partners feeling 
marginalized and wanting more information (Rowland & Metcalfe, 2014). They often 
reported that asking questions, specifically about physical alteration of the body or how 
to prepare to see surgical results, made them appear insensitive. Some male partners 
discussed their feelings with close family or friends, while others did not because they 
felt their concerns would appear superficial, resulting in backlash rather than support. 
These negative experiences discourage communication and could lead to suppression. 
Likewise, emotional suppression negatively impacts the relationship resulting in less 
feelings of acceptance causing distancing to occur (Cameron & Overall, 2017). Partners 
should be encouraged to have open communication, feel comfortable expressing 
concerns, and navigate the decision-making process together. 
Team Approach 
A recent study by Ahmad, Fergus, Shatokhina, and Gardner (2017) found that 
couple identity, or “we-ness,” increased a woman’s confidence in her ability to cope with 
cancer treatment and related stressors, thus improving individual adjustment. In 
communal coping, a stressor is a “we-event” in which both members of the relationship 
share responsibility for addressing the stressor through open communication and 
collaboration (Lyons, Mickelson, Sullivan, & Coyne, 1998). Similarly, a team approach 
as defined by Watts et al. (2011) is “the extent to which each member of the couple 
perceived himself or herself to adopt a collaborative approach to coping with the 
woman’s cancer risk, including engaging in open communication.” The “we-event” leads 
couples to feel that they are "in it together" which enhances relationship satisfaction 
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(Watts et al., 2011).  This allows the couple to express concerns and compassion, 
attenuate stress, and share the load of a disease or illness. Individual psychological 
adjustment improved for patients with chronic illness who perceived their partner to be 
involved through collaborations and support (Berg & Upchurch, 2007).  
A recent theoretical outline of thriving through relationships has postulated that 
collaborative action taken by a couple not only buffers stress but enhances individual and 
relationship outcomes (Feeney & Collins, 2015). To promote thriving, a partner provides 
encouragement or motivation, uses open communication, helps the individual frame a 
challenge as an opportunity for growth, assists with planning or set-backs, and 
encourages the individual to take action. This perspective takes team approach a step 
further, suggesting that gains can be made beyond simply maintaining levels of 
individual well-being or relationship satisfaction during a challenging time. This is 
consistent with other findings that for some couples, cancer strengthened their 
relationships with the spouse being caring and supportive, especially in couples who had 
been together longer (Rowland & Metcalfe, 2014).  
Hypotheses 
The present study explored the effects of a couples-based team approach to PBM 
on individual well-being. The first hypothesis was that women who experience social 
disapproval of their PBM would have poorer outcomes. Second, those with partners who 
take a team approach to their PBM will have greater individual well-being. Third, we 
hypothesized the interaction between negative feedback and team approach would still be 
present when controlling for marital duration, surgical complications, and SES. We also 
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investigated whether the association of PBM with lowered sexual satisfaction was 
influenced by the occurrence of prophylactic bilateral oophorectomy. 
Methods 
An online survey through Qualtrics was posted in various Facebook support 
groups. Women over 18 with a genetic mutation related to hereditary breast cancer, had a 
prophylactic bilateral mastectomy with or without breast reconstruction, and were in a 
committed romantic relationship at the time of the mastectomy were recruited. Although 
84 participants began the survey, there was a high attrition rate; only 62% completed all 
measures, leaving 53 participants.  
Participants 
Basic demographic information was collected along with information related to 
the surgery such as dates, number of surgeries, number of complications, reconstruction 
status, and type of HBOC mutation (see Table 1). This was a relatively homogeneous 
sample of primarily Caucasian (97%), North American women (86.8%), who were highly 
educated (59.8% with a 4-year degree or higher), and had a household income greater 
than $100,000 (64.2%). With respect to breast reconstruction, 51% had completed 
reconstruction, 32% were currently undergoing reconstruction, and 11% had opted out of 
reconstruction. Women ranged in ages from 25 to 64 years. The average relationship 
duration was 13.8 years, with only 7.5% of women having a relationship duration of less 
than 5 years. Only one participant was no longer in the same relationship as at the time of 
her PBM, although that relationship lasted 11 years. With respect to the mutations 
carried, 48% were BRCA 1, 48% were BRCA 2, and the remaining 4% were PALB2, 
CHEK2, or VUS.  
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Table 1 
Demographics. 
Participant Characteristics Frequency Percent 
Age    
25 – 34 11 20.8 
35 – 44 25 47.2 
45 – 54 11 20.8 
55 – 64 5 9.4 
 Missing 1 1.9 
Household Income    
Less than $20,000 2 3.8 
$20,000 - $59,999 7 13.2 
$60,000 - $99,999 10 18.9 
$100,000 - $139,999 18 34.0 
More than $140,000  16 30.2 
Education    
Less than high school degree 2 3.8 
High school graduate (or GED) 1 1.9 
Some college but no degree 5 9.4 
Associate degree or Trade 9 17.0 
Bachelor's degree  15 28.3 
Graduate or Professional degree 21 39.7 
Relationship Duration   
 3 - 5 years 4 7.5 
 6 - 10 years 15 28.3 
 11 - 15 years 12 22.6 
 16 - 20 years 5 6.1 
 20 - 25 years 7 13.2 
 More than 25 years 7 13.2 
 Missing 3 5.7 
Reconstruction Status    
Completed reconstruction 27 50.9 
Currently undergoing 
reconstruction 
17 32.1 
No reconstruction 6 11.3  
Missing 3 5.7 
Number of Complications    
0 18 34.0 
1 19 35.8 
2 6 11.3 
3 5 9.4 
4 4 7.5 
More than 5 1 1.9 
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Bilateral Oopherectomy   
 No 27 50.9 
  Yes 26 49.1 
 
Instruments 
Sources of negative social feedback. Participants were asked “Did you receive 
negative feedback from friends, family, acquaintances about your decision to have your 
prophylactic bilateral mastectomy (PBM)?  If yes, please check all of the following that 
apply.” Relationships listed were partner, immediate family, extended family, partner’s 
immediate family, partner’s extended family, close friends, other friends or 
acquaintances, and co-workers.  
Individual well-being. As indicators of individual well-being, we assessed 
mental health through the Depression, Anxiety, and Stress 21 item Scale (DASS21), 
rumination, and self-image through the Body Image Scale (BIS) and BREAST-Q. The 
DASS21 (Lovibond & Lovibond, 1995) has three subscales measuring depression, 
anxiety, and stress by a 4-point Likert scale ranging from 0 (Did not apply to me at all) to 
3 (Applied to me very much, or most of the time); Cronbach’s α = .95. Item example: “I 
couldn't seem to experience any positive feeling at all.” 
The Rumination scale (Nolen-Hoeksema, 2000) asks about the frequency of 
rumination on a Likert scale ranging from 1 (almost never) to 4 (almost always). The 
items ask what a person “generally” does when “they feel down sad or depressed”, such 
as how often they think “Why can’t I handle things better?” Scores can range from 22 to 
88, with an average score of 42 for women (Nolen-Hoeksema, Larson, & Grayson, 
1999); Cronbach’s α = .96.  
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The BIS (Fingeret, Vidrine, Arduino, & Gritz, 2007) has 8 items rated on a 4-
point scale of 0 (not at all) to 3 (very much).  A sample item is, “Have you been feeling 
less sexually attractive as a result of your disease or treatment?”; Cronbach’s α = .93.  
The BREAST-Q (Pusic et al., 2009) is a validated scale addressing quality of life 
and patient satisfaction following mastectomy and with a version for reconstruction and 
another for no reconstruction. We used the Satisfaction with Breasts (Cronbach’s α = 
.93), Psychosocial Well-Being (Cronbach’s α = .95), Sexual Well-Being (Cronbach’s α = 
.94), and Physical Well-Being Cronbach’s α = .91) subscales. 
Team approach. Literature on team approach or communal coping uses a two-
item scale with one item assessing open communication and the other assessing 
cooperative action, or dyadic coping (e.g., Watts et al., 2011; Biehle & Mickelson, 2011). 
To more thoroughly investigate these individual items, we selected validated scales 
related to each. We also included 3 survey-specific items on a sliding scale to assess “we-
ness” as a means of measuring communal coping as described below.  
To assess open communication, we included the Cancer-Related Communication 
Problems scale (CRCP; Kornblith et al., 2006). This is a 15 item, 5-point Likert scale 
ranging from 1 (very rarely) to 5 (very often). Modifications were made to apply to 
cancer prevention. Examples of modifications include adding the word “prevention” into 
items, such as “I talk over with my spouse about how cancer [prevention] treatment has 
changed my body (e.g., removal of breast, uterus, or ovaries),” or changing items to 
future tense such as from “having cancer” to “getting cancer“I don’t tell my spouse how 
scared I am about [getting] cancer.” Cronbach’s α = .80 with the modifications. 
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For cooperative action, we used the Dyadic Coping Inventory (DCI; Bodenmann, 
2008) and three survey-specific questions. The DCI is a 37-item, 3-point Likert scale 
anchored with 1 (not true), 2 (sometimes true), and 3 (often true), and includes items such 
as “We engage in a serious discussion about the problem and think through what has to 
be done.” Cronbach’s α = .94.  
We also created 3 new items to assess “We-ness” by positioning “we” statements 
juxtaposed to “I’ statements. We used a sliding scale ranging from partner not 
participating at all (“I” statements) to fully participating in treatment and planning 
(“We” statements). Scoring was done on a 1-10 sliding scale with the numeric values 
hidden from participants. The items were: “I attended all of my doctor appointments on 
my own” as opposed to “We attended all of the doctor appointments together,” “I made 
all decisions about my treatment on my own” as opposed to “We made all decisions 
about treatment as a team,” and “I am getting through this on my own” as opposed to 
“We are getting through this together.” Cronbach’s alpha for these items was only .64, 
so they were not included in the team approach composite score. 
Sexual satisfaction.  The Sexual Satisfaction Scale for Women (SSS-W; Meston 
& Trapnell, 2005) is a 30-item, 5-point Likert scale scored from 1 (strongly disagree) to 
5 (strongly agree) that touches on 5 domains examining Contentment, Communication, 
Compatibility, Personal Concern, and Relational Concern. Items were summed, allowing 
for scores from 30-150. Cronbach’s α = .96. 
Data Reduction and Analysis 
Missing data.  Inspection of the data revealed that the most common pattern of 
missingness was likely due to attrition.  There was progressively more missing data 
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throughout the survey scale by scale. The number of women who completed each scale, 
in the order they were presented, are shown in Table 2. Within the cases not affected by 
attrition, missing data values were less than 5% per scale. All scales were scored by 
computing an average of the items for the scale.  
Table 2 
 
Scale Completion and Missing Data Percentages 
 
Scales N Missing 
Depression, Anxiety, & Stress Scale 21 68 < 1 % 
Rumination Scale 66 < 1 % 
Body Image Scale 65 -  
Breast-Q Subscales 59 4 % 
Dyadic Coping Inventory 56 < 1 % 
Cancer-Related Communication Problems 53 < 1 % 
Sexual Satisfaction Scale 50 < 1 % 
 
Scale scoring and creation of composite indicators. For the DASS21, BIS, and 
Rumination Scale, item responses were averaged. An average was taken of the 
standardized scores for the Breast-Q Satisfaction with Breast, Psychosocial Well-Being, 
Sexual Well-Being, and Physical Well-Being subscales after scoring using the QScore 
software. A composite variable was made by summing the average Breast-Q subscale 
standardized scores and reversed standardized scores of the BIS, DASS21, and 
Rumination Scale so that higher scores indicated higher individual well-being. The scales 
scores included in the composite indicator for individual well-being were all correlated at 
p < .01. See Table 3 for the correlation matrix. 
For the DCI and CRCP, item responses were averaged. The standardized score for 
DCI and the reversed standardized score for CRCP were summed to create a composite 
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indicator for team approach. Higher values signal a stronger team approach. We chose 
not to include the survey-specific team approach questions, which had low correlations in 
our sample. See Table 3 for correlation matrix. 
Table 3 
Pearson Correlations among Study Variables 
 DASS21 Rumination Breast-Q CRCP DCI 
Body Image .42*** .34**       -.78**   .20         .06 
DASS21   .68***  -.48***   .28*  -.23 
Rumination 
  
 -.42***   .27   -.10 
Breast-Q Subscale 
Composite 
   
 -.38***   .07 
Cancer-Related 
Comm. Prob.   
  
 -.69*** 
* p < .05. ** p < .01. *** p < .001. 
Note. Correlations of variables composing Individual Well-Being are 
highlighted in light gray. Correlations of variables composing Team Approach 
are highlighted in dark gray.  
For Breast-Q subscale composite and Dyadic Coping Inventory, higher scores 
indicate higher well-being. For all other scales, lower scores indicate higher 
well-being. 
 
Results 
Negative feedback sources 
Approximately 60% of the sample received negative feedback from one or more 
sources. The most common sources of negative feedback were other friends or 
acquaintances (25%), extended family (23%), immediate family (17%), and close friends 
(15%).  
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Table 4 
Sources of Negative Feedback 
Negative feedback Frequency Percent 
Number of sources    
   0 21 39.6 
   1 17 32.1 
   2 12 22.6 
   3 1 1.9 
   4 1 1.9 
   5 1 1.9 
Source relationship   
   Partner 3 5.7 
   Immediate family 9 17.0 
   Extended family 12 22.6 
   Partner's immediate family 3 5.7 
   Partner's extended family 2 3.8 
   Close friends 8 15.1 
   Other friends/ acquaintances 13 24.5 
   Co-workers 4 7.5 
 
 
Social Disapproval and Team Approach 
To investigate our first hypothesis, that women who experience social disapproval 
of their PBM would have poorer outcomes, and our second hypothesis, that the 
relationship between negative feedback about the decision to undergo PBM and 
individual well-being would vary as a function of team approach, negative feedback 
(mean-centered), team approach (mean-centered), and an interaction term calculated from 
these variables were entered as predictors of individual well-being using the PROCESS 
macro (see Hayes, 2013).  Conditional main effects for negative feedback emerged, such 
that women who received negative feedback from more sources had poorer individual 
well-being, b = -.84, SE = .33, t(53) = -2.51, p = .02. These effects were qualified by a 
significant negative feedback and team approach interaction, b = .33, SE = .16, t(53) = 
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2.08, p = .04, ΔR2 = .07. Simple slopes analyses revealed that for women with relatively 
low (1 SD below the mean) and moderate (mean) levels of team approach, negative 
feedback significantly predicted poorer individual well-being, b = -1.46, SE = .49, t(53) = 
-2.98, p < .01, and b = -.84, SE = .33, t(53) = -2.51, p = .02, respectively. At high levels 
of team approach use (1 SD above the mean), negative feedback was uncorrelated with 
individual well-being, b = -.22, SE = .40, t(53) = -.56, p = .57. 
Figure 1 
Relationship between Negative Feedback and Individual Well-Being Varies as a Function 
of Team Approach 
 
Covariates. To test our third hypothesis, we controlled for marital duration, 
surgical complications, and SES (education or income). Each variable was entered as a 
covariate in the model one at a time. No covariates were significantly related to 
individual well-being.  To investigate the occurrence of statistical suppression, we 
examined changes in the interaction coefficients after covariates were added, as follows: 
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for number of complications, change in interaction coefficient = .01; for education, 
change in interaction coefficient = -.02; for income, change in interaction coefficient = 
.01; and for relationship duration, change in interaction coefficient = -.02. The interaction 
terms did not change by much (+/- .02) for any covariate, therefore, there is no indication 
of statistical suppression.  
Sexual Satisfaction 
 To investigate our research question, about a relationship existing between sexual 
outcome and coinciding oophorectomy, a regression analysis was performed. 
Oophorectomy, or surgical menopause, was not significantly related to sexual 
satisfaction, b = 1.82, SE = 5.91, t(53) = .31, p = .76. Scores for the SSS-W ranged from 
42 to 147 with a mean of 104.45 and standard deviation of 25.60.  
Discussion 
Social Disapproval  
Women who experienced social disapproval about their decision to have a PBM 
reported poorer individual well-being. These results are consistent with prior findings that 
negative social feedback about health care decisions can adversely impact individual 
well-being (Lloyd et al., 2000). Lloyd found that women received very “polarized” 
responses from those they decided to tell about their decision to have the PBM. Because 
negative opinions were so strong, the participants became selective in who else they told. 
This response has the potential to further limit a woman’s social support network.  
Team Approach 
Women with low levels of perceived team approach were more affected by 
negative feedback. Lack of support from one’s partner may compound the adverse effects 
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of social disapproval from other sources. Even at moderate levels of team approach, more 
social disapproval was also associated with increased adverse effects on individual well-
being, indicating that an average level of team approach does not fully attenuate the 
negative impact of stressors.  
On the other hand, for women who reported a stronger team approach, negative 
feedback from others was not related to their individual well-being. This is consistent 
with previous research indicating that team approach buffers adverse effects of stressors 
(Ahmad et al., 2017; Berg & Upchurch, 2007; Lyons et al., 1998). This finding 
exemplifies the strong buffering effect offered by a couples-based team approach. When 
a woman has her partner’s collaborative support, negative feedback from others does not 
affect her individual well-being. The dyadic coping and open communication comprising 
team approach allows the couple to express concerns and compassion, attenuate stress, 
and share the load of a disease or illness (Lyons et al., 1998). Having a partner in their 
corner to actively support and encourage their decisions likewise buffers against added 
stress from social disapproval. Ahmad (2017) found that partner support increases 
confidence in women’s ability to cope.  
Conversely, a study by M. den Heijer (2011) did not find a relationship between 
support offered by a significant other and individual well-being. Their model also 
included support from family and support from friends, both related to improved 
outcomes, which may overlap with support from a significant other. The authors 
acknowledged that this lack of relationship may have resulted from unclear instructions 
as to who to consider as a significant other. If the directions explicitly directed 
participants to think of a romantic significant other, the results may be in line with our 
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findings of support from a romantic close other. They did, however, find that open 
communication about hereditary risk also allows for opportunity for close others to help 
reframe cancer worries. Those women who feel supported by their close others are more 
likely to engage in open communication, possibly leading to improved individual well-
being (M. den Heijer et al., 2011).  
Surgical Menopause and Sexual Satisfaction 
Poorer sexual satisfaction was not related to oophorectomy. Previous research 
indicated mixed results regarding sexual well-being following PBM but failed to address 
coincidence of prophylactic oophorectomy. This study found no evidence that surgical 
menopause may be partially responsible for any decline in sexual satisfaction. A 
limitation, however, is that we did not ask if women who had an oophorectomy take 
hormone replacement therapy (HRT). HRT may mitigate adverse effects associated with 
menopause symptoms. 
Future Directions and Limitations  
One limitation of this study is that the measure of negative feedback women 
received about their decision may underestimate the number of sources. For example, a 
woman who checked that she received negative feedback from her immediate family may 
experience disapproval from both parents and multiple siblings, or simply from only one 
individual. The score for each of these women would be same for the present study. 
Given that negative feedback has been related to future selective disclosure (Lloyd et al., 
2000), it may be fruitful to investigate who women disclose to, the order in which they 
do, and whether negative feedback from close family and friends influences their 
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decisions to have the surgery. Additionally, it would be interesting to ask about how 
much they value each individual’s opinion on the matter. 
The high levels of education and household income within our sample raise a few 
questions. First, does this indicate that highly educated women are more familiar with 
information about PBM for risk management or have more access to it? Second, do 
women with higher incomes have access to better health care or more paid time off work, 
which in turn affords them the opportunity to have a PBM? Both questions may have 
grim implications. Women with lower SES may have less opportunity for prevention 
options. Hopefully, this is not the case, but rather an artifact of sampling error. Further 
research should investigate the incidence of PBM among women with a lower SES.  
Conclusion  
This is the first study to our knowledge that tests the effects of social disapproval 
about a medical decision on individual well-being. Women experiencing negative 
feedback about their decision who also lack the cooperative support of a partner may at 
be increased risk for poor individual well-being outcomes following PBM. Further 
exploration should investigate sources of collaborative support for single women. This is 
also the first study we know of that tests oophorectomy as a contributor to declines in 
sexual satisfaction outcomes typically associated with PBM.    
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APPENDIX A 
DEPRESSION, ANXIETY, & STRESS SCALE 21 
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DAS S 21 Name: Date: 
Please read each statement and circle a number 0, 1, 2 or 3 that indicates how much the statement applied to you over 
the past week.  There are no right or wrong answers.  Do not spend too much time on any statement. 
The rating scale is as follows: 
0  Did not apply to me at all 
1  Applied to me to some degree, or some of the time 
2  Applied to me to a considerable degree, or a good part of time 
3  Applied to me very much, or most of the time 
1 I found it hard to wind down 
0      1      2      3 
2 I was aware of dryness of my mouth 0      1      2      3 
3 I couldn't seem to experience any positive feeling at all 0      1      2      3 
4 I experienced breathing difficulty (eg, excessively rapid breathing, 
breathlessness in the absence of physical exertion) 
0      1      2      3 
5 I found it difficult to work up the initiative to do things 0      1      2      3 
6 I tended to over-react to situations 0      1      2      3 
7 I experienced trembling (eg, in the hands) 0      1      2      3 
8 I felt that I was using a lot of nervous energy 0      1      2      3 
9 I was worried about situations in which I might panic and make 
a fool of myself 
0      1      2      3 
10 I felt that I had nothing to look forward to 0      1      2      3 
11 I found myself getting agitated 0      1      2      3 
12 I found it difficult to relax 0      1      2      3 
13 I felt down-hearted and blue 0      1      2      3 
14 I was intolerant of anything that kept me from getting on with 
what I was doing 
0      1      2      3 
15 I felt I was close to panic 0      1      2      3 
16 I was unable to become enthusiastic about anything 0      1      2      3 
17 I felt I wasn't worth much as a person 0      1      2      3 
18 I felt that I was rather touchy 0      1      2      3 
19 I was aware of the action of my heart in the absence of physical 
exertion (eg, sense of heart rate increase, heart missing a beat) 
0      1      2      3 
20 I felt scared without any good reason 0      1      2      3 
21 I felt that life was meaningless 0      1      2      3 
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RUMINATION SCALE 
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Ruminations Scale 
People think and do many different things when they feel depressed. Please read each of the items 
below and indicate whether you almost never, sometimes, often, or almost always think or do 
each one when you feel down, sad, or depressed.  Please indicate what you generally do, not what 
you think you should do.  
                  1 - almost never;    2 - sometimes;    3 - often;    4 - almost always 
How often do you… 
- Think about how alone you feel 
- Think “I won’t be able to do my job if I don’t snap out of this” 
- Think about your feelings of fatigue and achiness 
- Think about how hard it is to concentrate 
- Think “What am I doing to deserve this?” 
- Think about how passive and unmotivated you feel. 
- Analyze recent events to try to understand why you are depressed 
- Think about how you don’t seem to feel anything anymore 
- Think “Why can’t I get going?” 
- Think “Why do I always react this way?” 
- Go away by yourself and think about why you feel this way 
- Write down what you are thinking about and analyze it 
- Think about a recent situation, wishing it had gone better 
- Think “I won’t be able to concentrate if I keep feeling this way.” 
- Think “Why do I have problems other people don’t have?” 
- Think “Why can’t I handle things better?” 
- Think about how sad you feel. 
- Think about all your shortcomings, failings, faults, mistakes 
- Think about how you don’t feel up to doing anything 
- Analyze your personality to try to understand why you are depressed 
- Go someplace alone to think about your feelings 
- Think about how angry you are with yourself 
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Body Image Scale 
________________________________________________________________________
Please indicate how often the following occur:   
 Not at all; Sometimes; Often; Very often 
Have you been feeling self-conscious 
about your appearance?  
 
Have you felt less physically attractive as a 
result of your treatment?  
 
Have you felt dissatisfied with your 
appearance when dressed?  
 
Have you been feeling less feminine as a 
result of your treatment?  
 
Did you find it difficult to look at yourself 
naked?  
 
Have you been feeling less sexually 
attractive as a result of your treatment?  
 
Did you avoid people because of the way 
you felt about your appearance?  
 
Have you felt dissatisfied about your 
body?  
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BREAST-Q – SELECT SUBSCALES 
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Breast-Q 
 
Response Options:  
None of the time; A little of the time; Some of the time; Most of the time; All of the time 
 
Satisfaction with Breasts Subscale 
 
With your breasts in mind, in the past 2 weeks, how satisfied or dissatisfied have you 
been with:  
 
- How you look in the mirror clothed? 
- The shape of your reconstructed breast(s) when you are wearing a bra? 
- How normal you feel in your clothes? 
- The size of your reconstructed breast(s)? 
- Being able to wear clothing that is more fitted? 
- How your breasts are lined up in relation to each other? 
- How comfortably your bras fit? 
- The softness of your reconstructed breast(s)? 
- How equal in size your breasts are to each other? 
- How natural your reconstructed breast(s) looks? 
- How naturally your reconstructed breast(s) sits/hangs? 
- How your reconstructed breast(s) feels to touch? 
- How much your reconstructed breast(s) feels like a natural part of your body? 
- How closely matched your breasts are to each other? 
- How your reconstructed breast(s) look now compared to before you had any breast 
surgery? 
- How you look in the mirror unclothed? 
 
Breast-Q Psychosocial Well-Being Subscale 
 
With your breasts in mind, in the past 2 weeks, how often have you felt:  
 
- Confident in a social setting? 
- Emotionally able to do the things that you want to do? 
- Emotionally healthy? 
- Of equal worth to other women? 
- Self-confident? 
- Feminine in your clothes? 
- Accepting of your body? 
- Normal? 
- Like other women? 
- Attractive? 
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Breast-Q Sexual Well-Being Subscale 
 
Thinking of your sexuality, since your breast reconstruction, how often do you generally 
feel:  
 
- Sexually attractive in your clothes? 
- Comfortable/at ease during sexual activity? 
- Confident sexually? 
- Satisfied with your sex-life? 
- Confident sexually about how your breast(s) look when unclothed? 
- Sexually attractive when unclothed 
 
Breast-Q Physical Well-Being Subscale 
 
In the past 2 weeks, how often have you experienced: - Neck pain? 
 
- Upper back pain? 
- Shoulder pain? 
- Arm pain? 
- Rib pain? 
- Pain in the muscles of your chest? 
- Difficulty lifting or moving your arms? 
- Difficulty sleeping because of discomfort in your breast area? 
- Tightness in your breast area? 
- Pulling in your breast area? 
- Nagging feeling in your breast area? 
- Tenderness in your breast area? 
- Sharp pains in your breast area? 
- Shooting pains in your breast area? 
- Aching feeling in your breast area? 
- Throbbing feeling in your breast area? 
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Dyadic Coping Inventory 
______________________________________________________________________________ 
This scale is designed to measure how you and your partner cope with stress. Please indicate the 
first response that you feel is appropriate. Please be as honest as possible. Please respond to any 
item by marking the appropriate case, which is fitting to your personal situation. There are no 
false answers.  
Responses:    very rarely;  rarely;  sometimes;  often;  very often  
______________________________________________________________________________  
This section is about how you communicate your stress to your partner.                                                            
1. I let my partner know that I appreciate his/her practical support, advice, or help.     
2. I ask my partner to do things for me when I have too much to do.  
3. I show my partner through my behavior when I am not doing well or when I have problems.  
4. I tell my partner openly how I feel and that I would appreciate his/her support.  
  
This section is about what your partner does when you are feeling stressed.   
5. My partner shows empathy and understanding to me.       
6. My partner expresses that he/she is on my side.       
7. My partner blames me for not coping well enough with stress.       
8. My partner helps me to see stressful situations in a different light.       
9. My partner listens to me and gives me the opportunity to communicate what really bothers me.  
10. My partner does not take my stress seriously.       
11. My partner provides support but does so unwillingly and unmotivated.  
12. My partner takes on things that I normally do in order to help me out.  
13. My partner helps me analyze the situation so that I can better face the problem.       
14. When I am too busy, my partner helps me out.       
15. When I am stressed, my partner tends to withdraw.       
  
This section is about how your partner communicates when he/she is feeling stressed.   
16. My partner lets me know that he/she appreciates my practical support, advice, or help.  
17. My partner asks me to do things for him/her when he has too much to do.  
18. My partner shows me through his/her behavior that he/she is not doing well or when he/she 
has problems.  
19. My partner tells me openly how he/she feels and that he/she would appreciate my support.  
      
This section is about what you do when your partner makes know his/her stress.   
 20. I show empathy and understanding to my partner.       
21. I express to my partner that I am on his/her side.       
22. I blame my partner for not coping well enough with stress.       
23. I tell my partner that his/her stress is not that bad and help him/her to see the situation in a 
different light.       
24. I listen to my partner and give him/her space and time to communicate what really bothers 
him/her.  
25. I do not take my partner’s stress seriously.       
26. When my partner is stressed I tend to withdraw.       
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27. I provide support, but do it so unwillingly and unmotivated because I think that he/she should 
cope with his/her problems on his/her own.  
28. I take on things that my partner would normally do in order to help him/her out.       
29. I try to analyze the situation together with my partner in an objective manner and help him/her 
to understand and change the problem.       
30. When my partner feels he/she has too much to do, I help him/her out.    
  
This section is about what you and your partner do when you are both feeling stressed.  
31. We try to cope with the problem together and search for ascertained solutions.  
32. We engage in a serious discussion about the problem and think through what has to be done.  
33. We help one another to put the problem in perspective and see it in a new light.  
34. We help each other relax with such things like massage, taking a bath together, or listening to 
music together.  
35. We are affectionate to each other, make love and try that way to cope with stress.  
 
This section is about how you evaluate your coping as a couple.  
36. I am satisfied with the support I receive from my partner and the way we deal with stress 
together.  
37. I am satisfied with the support I receive from my partner and I find as a couple, the way we 
deal with stress together is effective.  
_____________________________________________________________________________  
 
Copyright © 2008 Guy Bodenmann. Reproduced with Permission. The official citation that 
should be used when referencing this material is: Bodenmann, G. (2008). Dyadisches Coping 
Inventar: Testmanual [Dyadic Coping Inventory: Test manual]. Bern, Switzerland: Huber.  No 
further permission is needed for use or reproduction from Guy Bodenmann.  
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__________________________________________________________________________________________ 
Cancer Related Communication Problems 
___________________________________________________________________________ 
 
Please rate the following questions about cancer related partner communication as  
Not true, Sometimes true, or Often true. 
My partner understands what it was like for me to undergo treatment to prevent cancer.  
I don’t talk about my genetic predisposition problems with my partner because he/she gets 
upset when I do.  
My partner doesn’t ask how my genetic predisposition affected my life.  
I can’t talk about cancer with my partner because I get too upset.  
I never know when my partner wants to talk about my risk for getting cancer and when 
he/she does not.  
I talk over with my partner about how cancer prevention treatment has changed my body 
(e.g. removal of breast, ovaries, or uterus).  
I confide in my friends more than my partner about my cancer prevention experience.  
I talk with my partner about what to do if I am diagnosed with cancer.  
When it comes to cancer, I only tell my partner what he/she wants to hear.  
I don’t talk with my partner about how cancer prevention affects me sexually.  
________________________________________________________________________ 
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Sexual Satisfaction Scale for Women 
Question Response Options: 
Strongly disagree;      Disagree;  Neutral;      Agree;      Strongly agree 
I feel content with the way my present sex life is. 
I often feel something is missing from my present sex life.  
I often feel I don’t have enough emotional closeness in my sex life 
I feel content with how often I presently have sexual intimacy (kissing, intercourse, etc.) 
in my life.  
I don’t have any important problems or concerns about sex (arousal, orgasm, frequency, 
compatibility, communication, etc.).  
________________________________________________________________________ 
Question Response Options: 
Completely satisfactory;  Very satisfactory;   Reasonably satisfactory;  Not very 
satisfactory; Not at all satisfactory 
Overall, how satisfactory or unsatisfactory is your present sex life?  
________________________________________________________________________
Question Response Options: 
Strongly disagree;    Disagree;  Neutral;      Agree;      Strongly agree 
My partner often gets defensive when I try discussing sex.  
My partner and I do not discuss sex openly enough with each other, or do not discuss sex 
often enough.  
I usually feel completely comfortable discussing sex whenever my partner wants to 
My partner usually feels completely comfortable discussing sex whenever I want to. 
I have no difficulty talking about my deepest feelings and emotions when my partner 
wants me to.  
My partner has no difficulty talking about their deepest feelings and emotions when I 
want him to.  
I often feel my partner isn’t sensitive or aware enough about my sexual likes and desires.  
I often feel that my partner and I are not sexually compatible enough.  
I often feel that my partner’s beliefs and attitudes about sex are too different from mine. 
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I sometimes think my partner and I are mismatched in needs and desires concerning 
sexual intimacy. 
I sometimes feel that my partner and I might not be physically attracted to each other 
enough. 
I sometimes think my partner and I are mismatched in our sexual styles and preferences. 
I’m worried that my partner will become frustrated with my sexual difficulties. 
I’m worried that my sexual difficulties will adversely affect my relationship.  
I’m worried that my partner may have an affair because of my sexual difficulties. 
I’m worried that my partner is sexually unfulfilled.  
I’m worried that my partner views me as less of a woman because of my sexual 
difficulties.  
I feel like I’ve disappointed my partner by having sexual difficulties.  
My sexual difficulties are frustrating to me. 
My sexual difficulties make me feel sexually unfulfilled.  
I’m worried that my sexual difficulties might cause me to seek sexual fulfillment outside 
my relationship. 
I’m so distressed about my sexual difficulties that it affects the way I feel about myself.  
I’m so distressed about my sexual difficulties that it affects my own well-being 
My sexual difficulties annoy and anger me.  
___________________________________________________________________________ 
